Atrial Fibrillation Surgery Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Atrial Fibrillation Surgery Market is Segmented by Product (Catheter Ablation, and Surgical Ablation), End User (Hospitals, Ambulatory Surgical Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The report offers the value (in USD million) for the above segments.

Atrial Fibrillation Surgery Market Size

Atrial Fibrillation Surgery Market Overview

Atrial Fibrillation Surgery Market Analysis

The Global Atrial Fibrillation Surgery Market is expected to register a CAGR of 12.2% during the forecast period.

COVID-19 patients with cardiovascular disorders are at high risk and are most vulnerable to multiple organ failures, including myocarditis and rhythm disturbance. The data from Wuhan, China, has indicated that arrhythmia and acute cardiac injury were amongst the most prevalent heart complications in confirmed-positive cases of COVID-19. Furthermore, the February 2020 case report in the Journal of the American Medical Association (JAMA) identified common complications, such as shock (8.7%), acute respiratory distress syndrome (19.6%), arrhythmia (16.7%), and acute cardiac injury (17.2%) among hospitalized patients. Moreover, patients who received care in the ICU were more likely to have one of these complications than non-ICU patients.

Moreover, owing to the evolving public health crisis of COVID-19, remote monitoring allows clinicians to maintain necessary patient rapport with their healthcare provider when required. Healthcare providers can access information remotely about a patient's health while the patient is at home, which will reduce the need for hospital visits and minimize the risk of exposure to COVID-19. New technologies and digital platforms to aid in remote care should be developed, and further research on the role of telehealth, continuous data collecting, advanced automotive features, and remote patient monitoring is needed to guide best practices, which may fuel the growth of the studied market.

The atrial fibrillation market is driven by the rising prevalence of obesity and heart diseases across the globe. Additionally, heart diseases are one of the major causes of mortality across the globe, and due to the changing lifestyle, the number of people suffering from heart diseases is growing rapidly.

Additionally, the launch of new products in the market will further boost the market growth. For instance, in April 2022, AtriCure, Inc. launched the EnCompass Clamp, a part of the Isolator Synergy Ablation System in the United States. The EnCompass Clamp received FDA 510(k) clearance for ablation of cardiac tissue during cardiac surgery and is designed to make concomitant surgical ablations more efficient.

Furthermore, the rising research and development procedures highlighting the advancements in the Atrial fibrillation market will also boost the market. For instance, in January 2022, Peerbridge Health collaborated with Northwell Health on their newly launched AFib Center of Excellence, a multi-disciplinary effort that optimizes treatment for patients with atrial fibrillation (AFib). With Peerbridge's support, Northwell's AFib Center of Excellence will conduct a pilot program focusing on AFib patients with undiagnosed obstructive sleep apnea (OSA). The pilot aims to help cardiology and sleep physicians better understand the critical link between the two conditions and how best to quickly and effectively treat AFib and OSA concurrently. Thus, advancements in atrial fibrillation therapeutics are expected to drive the market.

Hence, owing to the aforementioned factors, the market studied is expected to grow in the forecast period. However, the high cost of procedures and regulatory issues associated with these devices is expected to hinder the market growth.

Atrial Fibrillation Surgery Industry Overview

The studied market is fragmented and moderately competitive. The market for atrial fibrillation consists of local as well as global companies, which are focusing on the development of new product launches and also witnessing the penetration of new entrants in the market. Technological advancements and the focus on improving the healthcare system are expected to influence more companies to enter the market, further driving market growth in the future. Major key players in the market include Boston Scientific Corporation, Medtronic Plc, Biotronik, AtriCure Inc., and Cardiofocus Inc., among others.

Atrial Fibrillation Surgery Market Leaders

  1. Boston Scientific Corporation

  2. Medtronic Plc

  3. Biotronik

  4. AtriCure, Inc.

  5. Cardiofocus, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
mark conc atrial 2.png
Need More Details on Market Players and Competiters?
Download PDF

Atrial Fibrillation Surgery Market News

  • In May 2022, Abbott reported positive results from the PERSIST-END study of its TactiCath Contact Force Ablation Catheter, Sensor Enabled (TactiCath SE) for persistent atrial fibrillation (AFib), the most common arrhythmia.
  • In April 2022, The Atrial Fibrillation Institute was established within the Queensland Cardiovascular Group (QCG) to provide a focused, specialist service for people with Atrial Fibrillation.

Atrial Fibrillation Surgery Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Obesity and Heart Diseases
    • 4.2.2 Rising Number of Programs to Enhance Public Awareness
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Procedure
    • 4.3.2 Regulatory Issues Associated with the Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - in USD Million)

  • 5.1 By Product
    • 5.1.1 Catheter Ablation
    • 5.1.2 Surgical Ablation
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Boston Scientific Corporation
    • 6.1.2 Medtronic PLC
    • 6.1.3 Biotronik SE & Co. KG
    • 6.1.4 AtriCure Inc.
    • 6.1.5 Cardiofocus Inc.
    • 6.1.6 Abbott Laboratories
    • 6.1.7 Johnson & Johnson
    • 6.1.8 MicroPort Scientific Corporation
    • 6.1.9 Koninklijke Philips NV
    • 6.1.10 Siemens AG
    • 6.1.11 Osypka AG
    • 6.1.12 Kardium Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Atrial Fibrillation Surgery Industry Segmentation

As per the scope of the report, atrial fibrillation (AF) is a common abnormal heart rhythm that occurs when electrical impulses fire off from different places in the atria in a disorganized way. It often begins as short periods of abnormal beating, which become longer or continuous over time. High blood pressure and valvular heart disease are the most common modifiable risk factors for AF. The atrial fibrillation surgery market is segmented by product (catheter ablation and surgical ablation), end user (hospitals, ambulatory surgical centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Catheter Ablation
Surgical Ablation
By End User Hospitals
Ambulatory Surgical Centers
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Atrial Fibrillation Surgery Market Research FAQs

What is the current Global Atrial Fibrillation Surgery Market size?

The Global Atrial Fibrillation Surgery Market is projected to register a CAGR of 12.2% during the forecast period (2025-2030)

Who are the key players in Global Atrial Fibrillation Surgery Market?

Boston Scientific Corporation, Medtronic Plc, Biotronik, AtriCure, Inc. and Cardiofocus, Inc. are the major companies operating in the Global Atrial Fibrillation Surgery Market.

Which is the fastest growing region in Global Atrial Fibrillation Surgery Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Atrial Fibrillation Surgery Market?

In 2025, the North America accounts for the largest market share in Global Atrial Fibrillation Surgery Market.

What years does this Global Atrial Fibrillation Surgery Market cover?

The report covers the Global Atrial Fibrillation Surgery Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Atrial Fibrillation Surgery Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Global Atrial Fibrillation Surgery Industry Report

Statistics for the 2025 Global Atrial Fibrillation Surgery market share, size and revenue growth rate, created by Mordor Intelligenceā„¢ Industry Reports. Global Atrial Fibrillation Surgery analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Global Atrial Fibrillation Surgery Report Snapshots

Compare market size and growth of Global Atrial Fibrillation Surgery Market with other markets in Healthcare Industry

Atrial Fibrillation Surgery Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)